Lindsey Sizemore

The Centers for Disease Control and Prevention (CDC) is the nation’s leading science-based, data-driven, service organization that protects the public’s health. To accomplish our mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats and responds when these arise. The Division of Viral Hepatitis is part of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention (NCHHSTP) at CDC. DVH consists of three branches—Epidemiology and Surveillance, Prevention, and Laboratory— that work collaboratively with the aim of ending the viral hepatitis epidemics by providing leadership in science and public health practices.

 

For the last decade, Lindsey has built capacity to address the downstream infectious consequences of the opioid crisis by developing services focused on groups experiencing a disproportionate impact to reach them in settings where they receive services. Currently, Lindsey leads one of three teams in the Prevention Branch of CDC DVH. In this capacity, Lindsey is responsible for providing subject matter expertise, leadership, and oversight in the implementation of viral hepatitis prevention, testing, and disease management recommendations and guidelines through strategic prioritization and program development. Prior to her role at CDC, Lindsey provided oversight to all aspects of the Tennessee Department of Health Viral Hepatitis Program, which consisted of over 30 employees statewide that conducted surveillance, offered prevention services, and provided linkage to treatment and harm reduction resources. Lindsey also worked with a core research team to update the Tennessee HIV and Hepatitis C Vulnerability Assessment, as well as with a multidisciplinary group on the End the Syndemic (HIV, Sexually Transmitted Infections, Viral Hepatitis, and Substance Use Disorder) Tennessee movement.